Gilead Sciences Inc. held its annual meeting of stockholders on May 7, 2025. Stockholders elected nine directors. A proposal for an independent Board Chair policy was not approved. A proposal requesting a comprehensive human rights policy and due diligence process was not approved. A proposal requesting a report on the risks of DEI practices for contractors was not approved. A proposal requesting the CEO pay ratio factor be included in executive compensation programs was not approved. The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000882095-25-000015), on May 08, 2025, and is solely responsible for the information contained therein.